Growth Metrics

Merck (MRK) Cash from Investing Activities (2016 - 2025)

Merck (MRK) has disclosed Cash from Investing Activities for 17 consecutive years, with -$11.2 billion as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 675.69% to -$11.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.7 billion through Dec 2025, down 77.67% year-over-year, with the annual reading at -$13.7 billion for FY2025, 77.67% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$11.2 billion at Merck, down from -$283.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $53.0 million in Q4 2023, with the low at -$12.0 billion in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$2.8 billion, with a median of -$1.3 billion recorded in 2022.
  • The sharpest move saw Cash from Investing Activities skyrocketed 103.03% in 2023, then plummeted 2824.53% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$12.0 billion in 2021, then soared by 85.49% to -$1.7 billion in 2022, then skyrocketed by 103.03% to $53.0 million in 2023, then tumbled by 2824.53% to -$1.4 billion in 2024, then plummeted by 675.69% to -$11.2 billion in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$11.2 billion, -$283.0 million, and -$770.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.